Erudio Healtherudio.com
Clinical trial · no report yet · Phase 2
IP2-ATLANTA
Additional Treatments to the Local Tumour for Metastatic Prostate Cancer: Assessment of Novel Treatment Algorithms
- NCT03763253 ↗
- Active, not recruiting
- Imperial College London
- Focused
We haven't built an HCP commentary report on IP2-ATLANTA yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on IP2-ATLANTA so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 3 |
The trial
ClinicalTrials.gov- Official title
- Local Cytoreductive Treatments for Men With Newly Diagnosed Metastatic Prostate Cancer in Addition to Standard of Care Treatment
- Phase
- Phase 2
- Status
- Active, not recruiting
- Conditions
- Prostate Cancer; Metastatic Prostate Cancer
- Interventions
- Standard of Care; Minimally Invasive Ablative Therapy (MIAT); Radical Therapy (Prostatectomy or Radiotherapy)
- Arms
- Control Arm: Standard of Care (SOC) · Active comparator
- Intervention Arm 1: Minimally Invasive Ablative Therapy (MIAT) · Active comparator
- Intervention Arm 2: Radical Therapy · Active comparator
- Enrollment
- 433
- Primary outcomes
- Prostate cancer on post-standard of care prostate biopsy.
- Safety (Adverse Events)
- Progression-free survival (PFS)
- Sponsor
- Imperial College London with Wellcome Trust
- Start
- Apr 10, 2019
- Primary completion
- Aug 31, 2026 (estimated)
- Results posted
- No
- Registry record
- NCT03763253 · updated Feb 7, 2025
Publications
linked from the registry- Connor MJ, Shah TT, Smigielska K, Day E, Sukumar J, Fiorentino F, Sarwar N, Gonzalez M, Falconer A, Klimowska-Nassar N, Evans M, Naismith OF, Thippu Jayaprakash K, Price D, Gayadeen S, Basak D, Horan G, McGrath J, Sheehan D, Kumar M, Ibrahim A, Brock C, Pearson RA, Anyamene N, Heath C, Shergill I, Rai B, Hellawell G, McCracken S, Khoubehi B, Mangar S, Khoo V, Dudderidge T, Staffurth JN, Winkler M, Ahmed HU. Additional Treatments to the Local tumour for metastatic prostate cancer-Assessment of Novel Treatment Algorithms (IP2-ATLANTA): protocol for a multicentre, phase II randomised controlled trial. BMJ Open. 2021 Feb 25;11(2):e042953. doi: 10.1136/bmjopen-2020-042953. PubMed 33632752